Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent genetic findings in schizophrenia and their therapeutic relevance
Paul J. Harrison
Journal of Psychopharmacology (2014) Vol. 29, Iss. 2, pp. 85-96
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention
Jeffrey A. Lieberman, Ragy R. Girgis, Gary Brucato, et al.
Molecular Psychiatry (2018) Vol. 23, Iss. 8, pp. 1764-1772
Open Access | Times Cited: 330
Hippocampal-Prefrontal Interactions in Cognition, Behavior and Psychiatric Disease
Torfi Sigurdsson, Sevil Duvarci
Frontiers in Systems Neuroscience (2016) Vol. 9
Open Access | Times Cited: 251
The origin of NMDA receptor hypofunction in schizophrenia
Kazu Nakazawa, Kiran Sapkota
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107426-107426
Open Access | Times Cited: 226
Human gene and disease associations for clinical‐genomics and precision medicine research
Zeeshan Ahmed, Saman Zeeshan, Dinesh Mendhe, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 1, pp. 297-318
Open Access | Times Cited: 195
The Emerging Neurobiology of Bipolar Disorder
Paul J. Harrison, John Geddes, Elizabeth M. Tunbridge
Trends in Neurosciences (2017) Vol. 41, Iss. 1, pp. 18-30
Open Access | Times Cited: 184
Ketamine and phencyclidine: the good, the bad and the unexpected
David Lodge, Marion Mercier
British Journal of Pharmacology (2015) Vol. 172, Iss. 17, pp. 4254-4276
Open Access | Times Cited: 166
Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study
Belinda Lennox, Emma Palmer‐Cooper, Thomas A. Pollak, et al.
The Lancet Psychiatry (2016) Vol. 4, Iss. 1, pp. 42-48
Open Access | Times Cited: 161
The current status of the magnocellular theory of developmental dyslexia
John Stein
Neuropsychologia (2018) Vol. 130, pp. 66-77
Closed Access | Times Cited: 156
A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data
Quan Wang, Rui Chen, Feixiong Cheng, et al.
Nature Neuroscience (2019) Vol. 22, Iss. 5, pp. 691-699
Open Access | Times Cited: 139
Patient Similarity Networks for Precision Medicine
Shraddha Pai, Gary D. Bader
Journal of Molecular Biology (2018) Vol. 430, Iss. 18, pp. 2924-2938
Open Access | Times Cited: 136
NMDAR Hypofunction Animal Models of Schizophrenia
Gloria Lee, Yi Zhou
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 126
Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion
Isabelle Cleynen, Worrawat Engchuan, Matthew S. Hestand, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 8, pp. 4496-4510
Open Access | Times Cited: 115
Innovative approaches to bipolar disorder and its treatment
Paul J. Harrison, Andrea Cipriani, Catherine J. Harmer, et al.
Annals of the New York Academy of Sciences (2016) Vol. 1366, Iss. 1, pp. 76-89
Open Access | Times Cited: 103
Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome
Anne S. Bassett, Chelsea Lowther, Daniele Merico, et al.
American Journal of Psychiatry (2017) Vol. 174, Iss. 11, pp. 1054-1063
Open Access | Times Cited: 89
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 57
The Underlying Neurobiological Mechanisms of Psychosis: Focus on Neurotransmission Dysregulation, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction
Neha S. Rawani, Allen W. Chan, Serdar Dursun, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 709-709
Open Access | Times Cited: 10
Animal models of gene–environment interaction in schizophrenia: A dimensional perspective
Yavuz Ayhan, Ross McFarland, Mikhail V. Pletnikov
Progress in Neurobiology (2015) Vol. 136, pp. 1-27
Open Access | Times Cited: 67
A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains
Siri Ranlund, Stella Calafato, Johan H. Thygesen, et al.
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2017) Vol. 177, Iss. 1, pp. 21-34
Open Access | Times Cited: 65
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models
Andrea Perrottelli, Francesco Flavio Marzocchi, Edoardo Caporusso, et al.
Journal of Psychiatry and Neuroscience (2024) Vol. 49, Iss. 2, pp. E109-E125
Open Access | Times Cited: 5
DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder
Alladi Charanraj Goud, Bruno Étain, Frank Bellivier, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3026-3026
Open Access | Times Cited: 57
Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer
Gerson D. Guercio, Rogério Panizzutti
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 55
Prenatal Maternal Stress and the Cascade of Risk to Schizophrenia Spectrum Disorders in Offspring
Emily Lipner, Shannon Murphy, Lauren M. Ellman
Current Psychiatry Reports (2019) Vol. 21, Iss. 10
Open Access | Times Cited: 52
The role of polygenic risk score gene-set analysis in the context of the omnigenic model of schizophrenia
Alexandros Rammos, Lara A. Neira Gonzalez, Daniel R. Weinberger, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 9, pp. 1562-1569
Open Access | Times Cited: 49
Integrative Transcriptomics Reveals Sexually Dimorphic Control of the Cholinergic/Neurokine Interface in Schizophrenia and Bipolar Disorder
Sebastian Lobentanzer, Geula Hanin, Jochen Klein, et al.
Cell Reports (2019) Vol. 29, Iss. 3, pp. 764-777.e5
Open Access | Times Cited: 48
Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review
J. Soler, Lourdes Fañanás, Mara Parellada, et al.
Journal of Psychiatry and Neuroscience (2018) Vol. 43, Iss. 4, pp. 223-244
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top